Health Care • Medical/Dental Instruments
$177.36 ▲ +4.56
(+2.64%)
MKT CAP: $91.65B • VOL: 2.50M
52W L $139 52W H $185
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$149
MEDIAN
$199
MEAN
$202
HIGH
$241
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE MMM TAPE
MMM // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $214.61 | $203.96 | 2025-02-14 | $161.40 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $223.47 | $209.28 | 2025-02-06 | $166.72 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $202.19 | $195.10 | 2025-01-29 | $170.27 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $180.91 | — | 2025-01-17 | $173.81 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $156.08 | $168.49 | 2025-01-09 | $157.85 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $211.06 | $184.45 | 2024-12-18 | $154.30 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $172.04 | $179.13 | 2024-12-04 | $164.94 | -4.3% | 48% | C |